CGA PS-54

CGA PS-54 CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases
en, Position Statement by Compressed Gas Association, 02/01/2018

More details

More info

Full Description

The U.S. Food and Drug Administration (FDA) drug registration and listing regulations, Title 21 of the U.S. Code of Federal Regulations (21 CFR) Part 207, do not address the unique properties of designated medical gas mixtures. Certain accommodations as presented in this position are made to conform with FDA?s requirements for electronic registration and listing submissions.

Product Details

Edition: 1st Published: 02/01/2018 Number of Pages: 2File Size: 1 file , 94 KB

Cart

Categories

CGA PS-54

CGA PS-54 CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases
en, Position Statement by Compressed Gas Association, 02/01/2018

Full Description

Product Details

Contact us

Cart

Categories

CGA PS-54

CGA PS-54 CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases en, Position Statement by Compressed Gas Association, 02/01/2018

Full Description

Product Details

Contact us

CGA PS-54 CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases
en, Position Statement by Compressed Gas Association, 02/01/2018